California to Begin Selling State-branded Insulin Beginning in 2026
Gavin Newsom, the Governor of California, announced this week that the State of California will get involved in pharma by offering state-branded insulin capped at 11 dollars per pen to California residents with diabetes beginning in 2026. Back in 2022 when Newsom first announced that California will address the high cost of insulin, it was suggested that the California could contract with Civica Rx, a non-profit drug manufacturer in Lehi, Utah, to produce and sell the state-branded insulin [for 11 dollars per pen], however, officials also suggested that state funds could be appropriated towards the development of a $50 million state-operated manufacturing plant in California. With the State of California now competing with Brand-name drug companies, people with insurance could pay even less for insulin if their insurer offers coverage of the state-branded insulin pens.
https://apnews.com/article/california-affordable-insulin-415edd0b915677d2051d22b4b8f8121c
https://calmatters.org/health/2025/10/insulin-california-announcement/
2 comments:
I like how you went into details about discussing California’s plan to sell its own insulin at a lower price, which could help many people afford their medication. If California can successfully sell cheaper insulin, should other states start making their own medicines too and what problems or benefits could come from that?
I think this is a great move in tackling overpriced medicine that is essential for people to live. This would also make insulin more accessible for people with diabetes, which makes me wonder how large pharmaceutical companies would respond when a government gets directly involved in the market. Do you think that this kind of government involvement would create new challenges in the pharmaceutical market?
Post a Comment